Towards β-globin gene-targeting with integrase-defective lentiviral vectors

Biotechnology Letters
Davoud Nouri InanlouS Zeinali

Abstract

We have developed an integrase-defective lentiviral (LV) vector in combination with a gene-targeting approach for gene therapy of β-thalassemia. The β-globin gene-targeting construct has two homologous stems including sequence upstream and downstream of the β-globin gene, a β-globin gene positioned between hygromycin and neomycin resistant genes and a herpes simplex virus type 1 thymidine kinase (HSVtk) suicide gene. Utilization of integrase-defective LV as a vector for the β-globin gene increased the number of selected clones relative to non-viral methods. This method represents an important step toward the ultimate goal of a clinical gene therapy for β-thalassemia.

References

Feb 11, 1988·Nucleic Acids Research·S A MillerH F Polesky
May 22, 2004·Journal of Biomedical Science·Andrew M L LeverJing Zhao
Oct 23, 2004·Best Practice & Research. Clinical Haematology·Michel SadelainIsabelle Rivière
Dec 21, 2004·British Journal of Haematology·Amit C NathwaniDavid C Linch
Jan 22, 2005·Trends in Biotechnology·Alexander A VolodinR Daniel Camerini-Otero
Nov 24, 2005·Hematology·Punam Malik, Paritha I Arumugam
Dec 13, 2005·Annals of the New York Academy of Sciences·Michel SadelainIsabelle Riviere
Feb 24, 2006·Nature Medicine·Rafael J Yáñez-MuñozAdrian J Thrasher
Mar 25, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sarah J NightingaleDonald B Kohn
May 6, 2006·Biochemical and Biophysical Research Communications·H KhanahmadS Zeinali
Nov 11, 2006·Proceedings of the National Academy of Sciences of the United States of America·Stéphanie PhilippeChe Serguera
Mar 7, 2007·Biochemical and Biophysical Research Communications·Hai-sheng ZhouChih-chuan Liang
Apr 5, 2007·Nature Protocols·Gustavo TiscorniaInder M Verma
Sep 18, 2007·Molecular Biotechnology·Adam S Cockrell, Tal Kafri
Apr 3, 2008·Pediatric Clinics of North America·Melody J Cunningham
Jun 17, 2008·Lancet·Alain Fischer, Marina Cavazzana-Calvo
Dec 19, 2008·Retrovirology·Olivier DelelisJean-François Mouscadet
Apr 4, 2009·European Journal of Haematology·Sadegh BabashahSirous Zeinali

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.